ZNF589
Basic information
Region (hg38): 3:48241100-48299253
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZNF589 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 15 | 19 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 10 | 11 | ||||
Total | 0 | 0 | 25 | 4 | 3 |
Variants in ZNF589
This is a list of pathogenic ClinVar variants found in the ZNF589 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-48241178-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
3-48241205-A-G | ZNF589-related disorder | Benign (Oct 25, 2019) | ||
3-48247686-G-A | ZNF589-related disorder | Benign (Jun 14, 2018) | ||
3-48260816-C-A | not specified | Uncertain significance (Aug 08, 2023) | ||
3-48260850-C-T | not specified | Uncertain significance (Aug 09, 2021) | ||
3-48260927-C-T | Likely benign (May 17, 2018) | |||
3-48267951-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
3-48267952-C-G | not specified | Uncertain significance (Feb 05, 2024) | ||
3-48268118-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
3-48268128-G-T | not specified | Uncertain significance (May 09, 2023) | ||
3-48268142-G-A | not specified | Uncertain significance (Dec 31, 2023) | ||
3-48268163-A-T | not specified | Uncertain significance (Nov 18, 2023) | ||
3-48268166-A-G | not specified | Uncertain significance (Jul 27, 2024) | ||
3-48268230-G-T | not specified • ZNF589-related disorder | Uncertain significance (Feb 15, 2023) | ||
3-48268290-T-C | not specified | Uncertain significance (Nov 13, 2024) | ||
3-48268296-G-T | not specified | Uncertain significance (Nov 24, 2024) | ||
3-48268310-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
3-48268338-C-G | ZNF589-related disorder | Benign (Oct 25, 2019) | ||
3-48268348-G-C | not specified | Uncertain significance (Dec 01, 2022) | ||
3-48268454-C-T | ZNF589-related disorder | Likely benign (Dec 13, 2018) | ||
3-48268455-G-C | not specified | Uncertain significance (Jul 30, 2024) | ||
3-48268484-A-C | not specified | Uncertain significance (Dec 04, 2024) | ||
3-48268515-C-T | not specified | Uncertain significance (Nov 30, 2022) | ||
3-48268526-G-A | not specified | Uncertain significance (Nov 13, 2023) | ||
3-48268565-C-T | ZNF589-related disorder | Likely benign (Apr 28, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZNF589 | protein_coding | protein_coding | ENST00000354698 | 4 | 58154 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00492 | 0.709 | 125206 | 0 | 6 | 125212 | 0.0000240 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0571 | 191 | 193 | 0.988 | 0.00000952 | 2366 |
Missense in Polyphen | 45 | 37.907 | 1.1871 | 488 | ||
Synonymous | 0.760 | 66 | 74.3 | 0.888 | 0.00000380 | 707 |
Loss of Function | 0.723 | 4 | 5.90 | 0.678 | 2.52e-7 | 61 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000558 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.0000558 | 0.0000544 |
South Asian | 0.000164 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in hematopoietic stem/progenitor cell differentiation. May play a role as a DNA binding-dependent transcriptional repressor. {ECO:0000269|PubMed:10029171, ECO:0000269|PubMed:12097288}.;
- Pathway
- Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription
(Consensus)
Recessive Scores
- pRec
- 0.0820
Intolerance Scores
- loftool
- 0.768
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 45.13
Haploinsufficiency Scores
- pHI
- 0.224
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.527
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.175
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;metal ion binding